2.3700
+0.1900
+(8.72%)
At close: January 10 at 4:00:00 PM EST
2.3200
-0.05
(-2.11%)
After hours: January 10 at 7:53:40 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 1 |
| Avg. Estimate | -0.96 | -0.67 | -2.62 | -0.41 |
| Low Estimate | -0.99 | -0.75 | -3.01 | -0.41 |
| High Estimate | -0.93 | -0.58 | -2.24 | -0.41 |
| Year Ago EPS | -0.78 | -1.55 | -3.99 | -2.62 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 6 | 3 |
| Avg. Estimate | -- | 702.6k | 7.63M | 57.72M |
| Low Estimate | -- | -- | -- | 49.2M |
| High Estimate | -- | 2.51M | 16M | 73M |
| Year Ago Sales | -- | -- | -- | 7.63M |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 656.15% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -1.07 | -1.08 | -0.84 | -0.9 |
| EPS Actual | -0.78 | -1.55 | -0.83 | -0.94 |
| Difference | 0.29 | -0.47 | 0.01 | -0.04 |
| Surprise % | 27.06% | -43.79% | 1.73% | -4.10% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.96 | -0.67 | -2.62 | -0.41 |
| 7 Days Ago | -0.83 | -0.62 | -2.38 | -0.33 |
| 30 Days Ago | -0.84 | -0.57 | -2.28 | -0.33 |
| 60 Days Ago | -0.84 | -0.57 | -2.28 | -0.33 |
| 90 Days Ago | -0.84 | -0.57 | -2.28 | -0.33 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | -- | -- | -- |
| Down Last 7 Days | 1 | 1 | 1 | 1 |
| Down Last 30 Days | 1 | 2 | 2 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| OTLK | -23.39% | 56.98% | 34.25% | 84.38% |
| S&P 500 | 8.66% | 11.51% | 14.05% | 13.39% |
Upgrades & Downgrades
| Downgrade | Chardan Capital: Buy to Neutral | 12/2/2024 |
| Maintains | BTIG: Buy to Buy | 11/29/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/29/2024 |
| Maintains | Chardan Capital: Buy to Buy | 8/16/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/15/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/17/2024 |
Related Tickers
APLT Applied Therapeutics, Inc.
0.6791
-6.40%
SYRS Syros Pharmaceuticals, Inc.
0.2250
+7.14%
CABA Cabaletta Bio, Inc.
2.0750
-10.56%
BLRX BioLineRx Ltd.
0.1429
+0.21%
NMRA Neumora Therapeutics, Inc.
2.2100
-6.75%
EPIX ESSA Pharma Inc.
1.7400
-4.40%
CRVO CervoMed Inc.
2.1100
-3.21%
TPST Tempest Therapeutics, Inc.
0.9494
-3.67%
EYEN Eyenovia, Inc.
0.1080
-9.77%
MURA Mural Oncology plc
3.8900
+6.58%